Proteomics-Based identification of dysregulated proteins and biomarker discovery in invasive ductal carcinoma, the most common breast cancer subtype
Invasive ductal carcinoma (IDC) is the most common histological subtype of malignant
breast cancer (BC), and accounts for 70–80% of all invasive BCs. IDC demonstrates great …
breast cancer (BC), and accounts for 70–80% of all invasive BCs. IDC demonstrates great …
Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance
J Wang, B Li, M Luo, J Huang, K Zhang… - … and Targeted Therapy, 2024 - nature.com
Ductal carcinoma in situ (DCIS) represents pre-invasive breast carcinoma. In untreated
cases, 25–60% DCIS progress to invasive ductal carcinoma (IDC). The challenge lies in …
cases, 25–60% DCIS progress to invasive ductal carcinoma (IDC). The challenge lies in …
High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer
The presence of immunosuppressive immune cells in tumors is a significant barrier to the
generation of therapeutic immune responses. Similarly, in vivo triple-negative breast cancer …
generation of therapeutic immune responses. Similarly, in vivo triple-negative breast cancer …
[HTML][HTML] MIND the translational gap: Preclinical models of ductal carcinoma in situ
SJ Hutten, J Jonkers - Clinical and Translational Medicine, 2023 - ncbi.nlm.nih.gov
Ductal carcinoma in situ (DCIS) is a non-invasive premalignant lesion and is considered a
non-obligate precursor of invasive breast cancer (IBC). DCIS has increasingly been …
non-obligate precursor of invasive breast cancer (IBC). DCIS has increasingly been …
Modeling intratumor heterogeneity in breast cancer
Reduced therapy response in breast cancer has been correlated with heterogeneity in
biomarker composition, expression level, and spatial distribution of cancer cells within a …
biomarker composition, expression level, and spatial distribution of cancer cells within a …
Trichinella spiralis Larval Extract as a Biological Anti‐Tumor Therapy in a Murine Model of Ehrlich Solid Carcinoma
Trichinella spiralis (T. spiralis) is an immunomodulating parasite that can adversely affect
tumor growth and extend host lifespan. The aim of this study was to elucidate the …
tumor growth and extend host lifespan. The aim of this study was to elucidate the …
The Pretenders: Basal Breast Cancer Cells Mimic Epidermal Keratinocytes and Rely on Retinoic Acid Signaling for Survival, Invasion and Metastasis
AE Doak - 2024 - search.proquest.com
In breast cancer, the presence of cells expressing basal epithelial markers is associated with
a high risk of tumor invasion, metastasis and therapy resistance. It has therefore been …
a high risk of tumor invasion, metastasis and therapy resistance. It has therefore been …
Clinicopathological features of breast cancer progression: From DCIS to invasive ductal carcinoma
J Zhang, N Aishan, BA SAAD, Y Chen, J Zhou, F Ji… - 2023 - researchsquare.com
Purpose Ductal carcinoma in situ (DCIS) is regarded as non-invasive precursor lesion of
invasive ductal carcinoma (IDC) but the molecular mechanisms and tumorigenesis behind …
invasive ductal carcinoma (IDC) but the molecular mechanisms and tumorigenesis behind …